-+ 0.00%
-+ 0.00%
-+ 0.00%

HELUS PHARMA EXEC SAYS JNJ'S SPRAVATO PROVIDES A GENERAL FRAMEWORK FOR PRICING

Reuters·11/16/2026 13:43:20